Find

  • All tenders
Portugal: Tenders/European Union Drugs Agency/MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration

MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration

Expired

The competition has expired without a winner being announced.

Deadline
14. okt.Expired
Award
Pris
Procedure
OpenSingle stage
Agreement
Buying services
Estimated value
€500Kover 3 years

Brief

The European Union Drugs Agency (EUDA) needs services for a "MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration" contract over 3 years, with a maximum total value of 500,000 EUR. The objective is to reinforce collective capacity across the EU to interpret toxicological findings and improve the detection, identification, and timely reporting of exposure to New Psychoactive Substances (NPS) and other illicit drugs by generating robust metabolic, pharmacological, and analytical data and consolidating these into a centralised, accessible EU database. The contract will be awarded based on quality and price.

Forskning og miljøovervåking

Register interest

Previous winners

  • Who are you up against?

    The suppliers who have won similar contracts at European Union Drugs Agency

Will you bid?

The agent sets up the bid and writes the first draft. Free for 14 days.

Award Criteria

  • Description

    Vennligst se anskaffelsesdokumentene for detaljer.

    Source

    No source found in the documents. Check the weight against the tender documents.

  • Description

    Vennligst se anskaffelsesdokumentene for detaljer.

    Source

    No source found in the documents. Check the weight against the tender documents.

From the notice

  • Regulation (EU) 2023/1322, which establishes the European Union Drugs Agency (EUDA), strengthens the Union’s preparedness for, and response to, drug-related health and security challenges. Article 15 in particular provides for a dedicated network of forensic and toxicology laboratories to enhance analytical capacity, harmonise methods, support quality assurance and facilitate the exchange of data and expertise across Member States. This strengthens and supports the timely detection, assessment and response to drug-related risks. Within this policy context, systematic investigation of drug metabolism is a cornerstone of clinical and forensic toxicology. Overall, the objective of this contract is to reinforce collective capacity across the EU to interpret toxicological findings and, critically, to improve the detection, identification, and timely reporting of exposure to NPS and other illicit drugs. By generating robust metabolic, pharmacological, and analytical data, and by consolidating these outputs into a centralised, accessible EU database, the project aims to strengthen timely reporting, harmonise practices, and ensure that toxicological evidence can be translated more effectively into monitoring, early warning, and public health responses to emerging NPS threats.

  • Contact

    infoprocurement@euda.europa.eu
  • Type
    Competition
  • Main code
    Research and development consultancy services
    73200000

Similar active competitions

  • European Union Drugs Agency

    Framework contract for EUDA scientific studies support services

    The European Union Drugs Agency (EUDA) needs scientific studies support services through a framework agreement over 4 years, with a maximum total value of 8,000,000 EUR. The procurement aims to acquire external expertise for the design, conduct, and reporting of scientific work, including reports, digital dashboards, AI-based tools, methodological guidelines, training materials, workshops, databases, and literature collection. This support will enhance EUDA's capacity to monitor drug markets, substance use, and their consequences, and to identify evidence for informing responses to drug-related harms. The award criteria are Quality (70%) and Price (30%).

    Framework agreement
    2. des. 2026(10 days)
    €8,000,000
  • Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

    Forskning og utdanning

    Facilitating the implementation of decentralised manufacturing for biotech medicinal products

    Health and Digital Executive Agency (HaDEA) is planning the procurement of services to facilitate the implementation of decentralised manufacturing for biotech medicinal products, with an estimated maximum total contract value of 3,000,000 EUR over 3 years. The purpose is to support developers of biotech medicinal products in implementing a new decentralised procedure manufacturing set-up for their products.

    Planning
    2. feb. 2027(72 days)
    €3,000,000
  • European Medicines Agency

    Forskning og miljøovervåking

    Open call for scientific and regulatory experts

    The European Medicines Agency needs scientific and regulatory experts for a 5-year period to provide advice on scientific, regulatory, and training activities related to medicines for human use and veterinary medicinal products. The services will support the Agency within the scope of Article 57(1) of Regulation (EC) No 726/2004 and Regulation (EU) 2022/123, as provided in Article 242 of Regulation (EU, Euratom) 2024/2509 (EU Financial Regulation).

    Competition
    31. des. 2030(100+ days)